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INTRODUCTION
Examination of the bone marrow is one of the 
most valuable diagnostic tests used to evaluate 
haematological disorders. Bone marrow aspiration 
and biopsy is also used to stage lymphoproliferative 
disorders and for prognostic purposes in chronic 
lymphoproliferative disorders such as chronic 
lymphocytic leukaemia. 
 Bone marrow aspiration and biopsy is also 
useful in the diagnostic workup of fever of unknown 
origin. It may reveal infections, such as tuberculosis, 
mycobacterium avium-intracellulare infections, 
histoplasmosis, leishmaniasis, and other disseminated 
fungal infections. It may be useful in establishing the 
diagnosis of storage diseases and diagnosing metastatic 
non-haemopoietic malignancies that have spread to the 
bone marrow when all other imaging and diagnostic 
modalities have failed or when a leucoerythroblastic 
peripheral blood picture is present (1). 
 It is usually not indicated in haemolytic anaemia 
and is contraindicated in haemophilia and related 
congenital haemorrhagic disorders. Deviations from 
the normal may be qualitative with abnormal cellular 
morphology or quantitative with aplasia, hypoplasia 
or hyperplasia (2). Injury to the great vessels is a 
serious albeit rare complication of bone marrow 
sternal puncture. 
The objective of this study was to establish the bone 
marrow examination ﬁndings and indications for 
bone marrow examination at Aga Khan University 
Hospital, Nairobi. 
MATERIALS AND METHODS
This was a retrospective audit. All patients who 
underwent bone marrow aspiration during the period 
February, 2003 to February, 2006 were included in 
this study. Every patient’s history was examined 
in detail and ﬁndings were recorded on a standard 
proforma including demographic data, symptoms 
and signs and all the relevant investigations. Bone 
marrow aspiration results were also recorded. Data 
was analysed to know the relative frequencies of 
different haematological disorders in our patients 
and also establish the indications for bone marrow 
examination. 
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ABSTRACT
Objective: To establish the bone marrow examination ﬁndings and determine the 
indication for bone marrow examination. 
Design: A retrospective audit. 
Setting: Aga Khan University Hospital, Nairobi.
Subjects: All bone marrow aspirates done at Aga Khan University for the period 
comprising February 2003 to February 2006 were retrieved and analysed. 
Results: A total of 356 patient’s case histories including bone marrow examination 
results were analysed. Ages of the patients ranged from 18 months to 91 years. Males 
were 180 (50.6%) and females were 176 (49.4%). Nutritional anaemia as a group was 
the most common haematological disorder found on bone marrow examination in our 
patients with megaloblastic anaemia predominating. Acute myeloid leukaemia was 
the most common malignant haematological disorder. The most common indication 
for bone marrow examination was anaemia followed by diagnostic work up of fever 
of unknown origin. 
Conclusion: Nutritional anaemia predominated as the commonest benign haematological 
ﬁnding on bone marrow examination while acute myeloid leukaemia was the most 
frequent haematological malignancy. Most bone marrow examinations were performed 
on patients with anaemia. 
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RESULTS
A total of 356 patient’s case histories including bone 
marrow examination results were analysed. Ages of the 
patients ranged between 18 months to 91 years. Males 
were 180 (50.6%) and females were 176 (49.4%).
 The indication for the bone marrow examination 
were anaemia (26.9%), bone marrow cultures 
(17.5%), pancytopenia (17.1%), confirmation of 
acute leukaemia or lymphoproliferative disorders 
(10.9%), leukoerythroblastic picture (7.5%), exclusion 
of multiple myeloma (8.4%), staging of lymphomas 
(6.5%), mono cytopenias (5%) (Table 1). 
Table 1
Indications for bone marrow examination
Indication Cases
 No.  (%)
Anaemia  96   26.9
Pyrexia of unknown origin 62   17.5
Pancytopenia 61   17.1
Conﬁrmed leukaemia (acute, chronic) 36   10.9
Leucoerythroblastic picture 27   7.5
Staging of lymphomas 21   6.1
Mono cytopenias 18   5
Indication for bone marrow examination not stated 35   9
Total 356
 Nutritional anaemia contributed 14.9% amongst 
the non-malignant haematological disorders. Out of 
nutritional anaemia, megaloblastic anaemia was the 
most common i.e. (8.1%) followed by iron deﬁciency 
anaemia (6.5%) and mixed deﬁciencies (0.3%). 
 Other non-malignant haematological disorders 
were aplastic anaemia (1.3%), pure red cell aplasia 
(0.6%), anaemia of chronic disease (0.6%) idiopathic 
thrombocytopaenic purpura (ITP) (4.2%), infections 
(fungal, tuberculosis, typhoid fever, malaria) (3.7%) 
including HIV dyspoiesis (7.3%) (Table 2). 
Table 2
Spectrum of non-malignant haematological conditions
Disease Cases
 No.  (%)
Infections including HIV dyspoiesis 39    11
Megaloblastic anaemia 29    8.1
Iron deﬁciency anaemia 23    6.5
ITP 15    4.7
Aplastic anaemia 5     1.3
Suppression of bone marrow 
by cytotoxics 4     1.2
Haemolytic anaemia 4     1.2
Anaemia of chronic disease 2     0.6
Pure red cell aplasia 2     0.6
Mixed deﬁciency 1     0.3
Total 124   35
Table 3
Spectrum of malignant haematological conditions
Disease Cases 
 No.  (%)
Acute myeloid leukaemia 29   8.6
Lymphoproliferative disorders 24   6.7
Multiple myeloma 20   5.6
Myeloproliferative disorders/
myelodysplastic syndrome 9    2
Metastatic tumours to the 
bone marrow 9    2
Acute lymphoblastic leukaemia 6    1.7
Total 97  26.6 
 Haematinic deficiency was most common 
in young adults (19-40 years) (Table 4) so was 
aplastic anaemia and ITP; the mentioned disorders 
were also commoner in females. Haematological 
malignancies had a varied distribution with the 
myeloid leukaemia and lymphoproliferative 
disorders being commoner in young adults and 
myeloproliferative/myelodysplastic disorders 
occurring more in the older age group i.e. >40 years 
with a more  preponderance for  males  (Table 5). 
Acute lymphoblastic leukaemia was commoner in 
the younger age group less the 18 years with an 
equal sex distribution. 
 Acute myeloid leukaemia accounted for (8.1%) 
and was found to be the most common malignant 
disorder, followed by low grade lymphoproliferative 
disorders - chronic lymphocytic leukaemia (6.7%), 
multiple myeloma (5.6%), acute lymphoblastic 
leukaemia (5.6%), myeloproliferative disorders and 
myelodysplastic syndromes (2%), bone marrow 
metastasis (2.2%). Other miscellaneous findings 
included normal marrow (20.8%), reactive marrow 
(14.3%) and inadequacy of material for proper 
evaluation (2.8%) (Table 3). 
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Table 4
Age distribution of bone marrow aspirate ﬁndings
Bone marrow ﬁnding  1-18 years  19-40 years  >40 years  Total cases 
  % cases  % cases  % cases  
Infections including HIV dyspoiesis  10 67 23 39 
Megaloblastic anaemia  21 52 27 29 
Iron deﬁciency anaemia  17 57 26 23 
ITP 67 33 15 
Aplastic anaemia  0 100 0 5 
Bone marrow suppression by drugs  0 0 100 4 
Haemolytic anaemia  0 50 50 4 
Anaemia of chronic diseases  0 100 0 2 
Pure red cell aplasia  50 50 0 2 
Mixed deﬁciency  100 0 0 1 
Acute myeloid leukaemia  11 50 39 29 
Lymphoproliferative disorders  7 50 43 24 
Multiple myeloma  5 18 77 20 
Myeloproliferative  
disorders/myelodysplastic syndrome  12 41 47 9 
Metastatic tumour to the bone marrow  0 67 33 9 
Acute lymphoblastic leukaemia  50 33 17 6 
Normal marrow  15 43 42 74 
Reactive marrow  7 46 47 51 
Inadequate material for evaluation  50 20 30  10 
ITP = Idiopathic thrombocytopaenic purpura
Table 5
Sex distribution of bone marrow aspirate ﬁndings
Bone marrow ﬁnding  Female  Male  Total cases 
 % cases  % cases  
Infections including HIV dyspoiesis  42  58  39 
Megaloblastic anaemia  66  34  29 
Iron deﬁciency anaemia  56  44  23 
ITP  66  34  15 
Aplastic anaemia  50  50  5 
Bone marrow suppression by drugs  60  40  4 
Haemolytic anaemia  75  25  4 
Anaemia of chronic diseases  0  100  2 
Pure red cell aplasia  50  50  2 
Mixed deﬁciency  100  0  1 
Acute myeloid leukaemia  42  58  29 
Lymphoproliferative disorders  50  50  24 
Multiple myeloma  59  41  20 
Myeloproliferative disorders/myelodysplastic syndrome  47  53  9 
Metastatic tumour to the bone marrow  33  67  9 
Acute lymphoblastic leukaemia  50  50  6 
Normal marrow  42  58  74 
Reactive marrow  47  53  51 
Inadequate material for evaluation  50  50  10 
ITP = Idiopathic thrombocytopenic purpura
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DISCUSSION
The spectrum of haematological disorders in patients 
is very wide. Bone marrow examination is a useful 
test in reaching the ﬁnal diagnosis. It is one of the 
most common and relatively safe procedures done 
on patients in medical practice although injury to 
the great vessels may be a rare complication of bone 
marrow sternal puncture. Rarely have infection, 
excessive bleeding or embolism been reported after 
bone marrow biopsy (3). 
 This study shows that amongst the micronutrient 
anaemia, megaloblastic anaemia is the most common 
non-malignant disorder in our patients. In other 
similar studies its frequency ranges from as low as 
24% to as high as 68% (4, 5). In almost all these studies 
pancytopenia was the main presentation and so was 
the case in our study. Rarely megaloblastic anaemia 
may present with thrombocytopenia only (6). 
 The cause of megaloblastic anaemia is folate 
deﬁciency and vitamin B12 deﬁciency. The usual 
presenting feature of megaloblastic anaemia 
in our patients was macrocytic anaemia and 
symptoms of pancytopenia (thrombocytopenia and 
neutropenia). 
 Amongst other micronutrient anaemia, iron 
deﬁciency accounted for 6.5% only. This percentage is 
much lower than expected as an estimated 60 to 80% of 
the world’s population has this nutritional deﬁciency 
(7). The possible explanation is that majority of the 
patients are diagnosed on peripheral blood smear 
examination and on serum ferritin levels and are 
treated as outpatients. 
 Aplastic anaemia was also reported in some 
of our patients (1.3%). Epidemiologically, aplastic 
anaemia has a pattern of geographic variation 
opposite to that of leukaemia, with higher frequency 
in the developing world than in the industrialised 
West. Although not a common disease worldwide, 
aplastic anaemia has a social impact disproportionate 
to its incidence. Large prospective studies indicate 
an annual incidence of two new cases per million 
populations in Europe and Israel (8). The rate is 
much higher in the developing world, where aplastic 
anaemia may rival acute myelogenous leukaemia in 
frequency of diagnosis in haematology clinics. This 
has been shown from the studies in Thailand and 
China, where the incidence has been determined 
to be about threefold that in the West (9). European 
studies have conﬁrmed and quantiﬁed medical 
drugs as risks for the development of marrow failure. 
Surprisingly, drug use accounts for only a small 
fraction of the disease in Thailand, where it is almost 
always idiopathic. Prognosis is directly related to the 
reduction in peripheral blood counts, particularly 
the neutrophil number: < 200 granulocytes/µL 
deﬁnes the category of severe disease (10). Recurrent 
bacterial sepsis or fungal invasion of critical organs 
secondary to refractory neutropenia is the usual cause 
of death. Its exact aetiology is still not known but 
an autoimmune mechanism has been inferred from 
positive responses to non transplant therapies and 
laboratory data (11). 
 Idiopathic thrombocytopaenia purpura was the 
third most common non malignant haematological 
disorder found on bone marrow examination in our 
patients. Idiopathic thrombocytopaenic purpura 
(ITP) is a condition of having a low platelet count 
(thrombocytopenia) of no known cause (idiopathic). 
As most causes appear to be related to antibodies 
against platelets, it is also known as immune 
thrombocytopenic purpura. The incidence of ITP is 
50-100 new cases per million per year, with children 
accounting for half of that amount. More than 70% of 
the cases in children end up in remission within six 
months whether treated or not. Moreover, a third of 
the remaining chronic cases remit during the follow-
up observation, and another third ended up with only 
mild thrombocytopenia (>50,000 platelets per µL) 
(12). The paediatric age group in our study did not 
have a case of ITP and this can be attributed to the 
fact that bone marrow examination is hardly ever 
needed to make a diagnosis of paediatric ITP. ITP is 
usually chronic in adults (13) and the probability of 
durable remission is 20-40% (14). The male: female 
ratio in the adult group is 1:1.2-1.7 (for children it is 
1:1) and the median age of adults at the diagnosis 
is 56-60 (15). This was hardly the case in our study 
where the condition was rampant in the young adults 
(19-40 years). 
 In this study, 29 (8.1%) cases of leukaemia 
were noted, with acute myeloid leukaemia being 
the commonest, which was followed by low grade 
lymphoproliferative disorders mainly chronic 
lymphocytic leukaemia. Acute myeloid leukaemia 
(AML), also known as acute myelogenous leukaemia, 
is a cancer of the myeloid line of leucocytes, 
characterised by the rapid proliferation of abnormal 
cells which accumulate in the bone marrow and 
interfere with the production of normal blood cells. 
AML is the most common acute leukaemia affecting 
adults, and its incidence increases with age. Although 
AML is a relatively rare disease, accounting for 
approximately 1.2% of cancer deaths in the United 
States (16) its incidence is expected to increase as 
the population ages. 
 Normal and reactive bone marrows were 
found in one third of our patients and therefore a 
conﬁrmatory diagnosis was made in two thirds of 
the patients. This goes to show that bone marrow 
examination is a useful test and diagnosis can be 
made in a majority of patients, where the procedure 
is indicated. 
 In about 2.8%, the bone marrow aspirate material 
was inadequate for evaluation and this could point 
towards a ﬁbrotic lesion in the bone marrow or 
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inadequate technique. This procedure is fairly easy 
to perform and yields information in almost all bone 
marrow examination, as shown by the low incidences 
of getting inadequate material for evaluation. 
In conclusion, amongst the non-malignant 
haematological disorders, nutritional anaemia as a 
group was the most common disorder found on bone 
marrow examination in this study, megaloblastic 
anaemia being the most common followed by 
iron deﬁciency anaemia. HIV dyspoiesis was the 
second commonest bone marrow ﬁnding in this 
study. Acute myeloid leukaemia was the most 
common haematological malignancy followed by 
lymphoproliferative disorders. The most common 
indication for bone marrow examination was anaemia 
followed by bone marrow cultures for diagnostic 
work up of fever of unknown origin. 
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